Oruka Therapeutics (ORKA) insider trading in the last 6 months

4 insiders sold $301M. No buys.

Quality Score7Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 7 tradesSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellLawrence Otto Klein$235KChief Executive Officerat $95.71 on Sep 15, filed Sep 15

SellLawrence Otto KleinChief Executive Officer$235Kat $95.71 on Sep 15, filed Sep 15

SellPaul T. Quinlan$99KGeneral Counselat $95.71 on Sep 15, filed Sep 15

SellPaul T. QuinlanGeneral Counsel$99Kat $95.71 on Sep 15, filed Sep 15

SellLaura Lee Sandler$87KChief Operating Officerat $95.71 on Sep 15, filed Sep 15

SellLaura Lee SandlerChief Operating Officer$87Kat $95.71 on Sep 15, filed Sep 15

From SEC Form 4s, the newest filed Sep 15, 2026 · Insiders have 2 business days to file a trade

4 more filings on ORKA in the last 6 months, for Pro members. See them free →

Pro members see every filing on ORKA with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Oruka Therapeutics

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about ORKA's insider trades

As of Nov 9, 2026: Oruka Therapeutics (ORKA) has 7 insider filings on record in the last 6 months, the newest filed Sep 15, 2026. Its Quality Score is 7 (Average). Scores as of 9:05 AM ET, 15 minutes behind.

Are ORKA insiders buying or selling?

4 insiders sold $301M across 7 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Lawrence Otto Klein, Chief Executive Officer, sold $235K on Sep 15, 2026.

Who are ORKA's biggest insider sellers?

By the dollars of their sales in the last 6 months: Fairmount Funds Management LLC (10% owner), 1 sale; Lawrence Otto Klein (Chief Executive Officer), 2 sales; Paul T. Quinlan (General Counsel), 2 sales. 4 insiders sold in all.

When did an ORKA insider last buy?

No ORKA insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Lawrence Otto Klein on Sep 15, 2026.

Oruka Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Oruka Therapeutics (ORKA) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Oruka Therapeutics

Questions about ORKA's insider trades

Every insider trade, with its stock's score.